Balance Sheet Data

Pieris Pharmaceuticals, Inc. (PIRS)

$1.8

+0.06 (+3.45%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 72.63128.11104.1570.44117.76109.51121.74135.33150.45167.25
Total Cash (%)
Account Receivables 15.552.706.791.713.317.117.918.799.7710.86
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 2.453.355.803.0111.595.656.286.987.768.63
Accounts Payable (%)
Capital Expenditure -1.95-1.70-2.46-2.73-0.95-2.18-2.42-2.69-2.99-3.33
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.